Inside these posts: Mylotarg

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.

 

Pfizer to pull leukemia treatment

Drugmaker Pfizer Inc. is pulling a decade-old leukemia medicine off the U.S. market after a study found a higher death rate and no benefit for patients.

Mylotarg won approval under an abbreviated process to help bring treatments for serious diseases to patients more quickly. Medicines cleared in that way must pass follow-up tests to confirm they work. Get the full story »